Merus’ Cancer Drug, Investors Are Waiting and Watching

Merus is expecting to release early Phase 1 results for its drug for colorectal cancer in the first quarter 2020.

Most Popular

Zogenix FDA Approval, How This Small Cap is Trying to Cure a Rare Condition

Zogenix looks to the FDA for approval of its promising treatment for Dravet Syndrome

Anticipation for Avadel Pharmaceuticals Narcolepsy Drug Launches the Stock Up 1000%

Avadel is expecting Phase 3 results for its narcolepsy drug in the second quarter of 2020.

Eton Pharmaceuticals Revamps Proven Winners, But Will Stock Move?

Eton has an FDA approval date on March 17th for a reformulated drug.

Stay connected